Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.650
+0.330 (14.22%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Dogwood Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-36.04-34.26-12.35-5.3-12.25-15.96
Depreciation & Amortization
0.070.070.01---
Other Amortization
-0.050.06---
Loss (Gain) From Sale of Assets
00----
Asset Writedown & Restructuring Costs
11.9111.91----
Stock-Based Compensation
1.20.360.480.620.580.32
Other Operating Activities
6.86.383.59---
Change in Accounts Payable
-0.12-0.530.22-0.460.220.27
Change in Other Net Operating Assets
1.070.4-0.80.27-0.02-0.32
Operating Cash Flow
-15.11-15.62-8.79-4.87-11.47-15.69
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Acquisitions
--3.76---
Investing Cash Flow
--3.76---

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-315.32---
Net Debt Issued (Repaid)
-315.32---
Issuance of Common Stock
11.484.341.381.164.490.2
Repurchase of Common Stock
-0.11--0---
Other Financing Activities
-0.05-0.05----0.3
Financing Cash Flow
11.327.2816.71.164.49-0.1

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.010.01-0.14---
Net Cash Flow
-3.79-8.3211.53-3.71-6.98-15.79

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-16.36-17.34-5.23-2.98-6.92-9.8
Unlevered Free Cash Flow
-16.36-17.39-5.23-2.98-6.92-9.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.95-0.13-0.58-0.190.2-0.05
SEC Filings: 10-K · 10-Q